about
Molecular evolution of the human SRPX2 gene that causes brain disorders of the Rolandic and Sylvian speech areasSevere epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2AHIV-1 infection and first line ART induced differential responses in mitochondria from blood lymphocytes and monocytes: the ANRS EP45 "Aging" studyFunctional variant in complement C3 gene promoter and genetic susceptibility to temporal lobe epilepsy and febrile seizuresInfantile convulsions with paroxysmal dyskinesia (ICCA syndrome) and copy number variation at human chromosome 16p11.Cytogenetic study of six cases of radiation-induced meningiomas.Molecular networks implicated in speech-related disorders: FOXP2 regulates the SRPX2/uPAR complex.SRPX2 mutations in disorders of language cortex and cognition.HIV protease inhibitors do not cause the accumulation of prelamin A in PBMCs from patients receiving first line therapy: the ANRS EP45 "aging" studyGenetics of infantile seizures with paroxysmal dyskinesia: the infantile convulsions and choreoathetosis (ICCA) and ICCA-related syndromes.New ZMPSTE24 (FACE1) mutations in patients affected with restrictive dermopathy or related progeroid syndromes and mutation update.Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions.Truncated prelamin A expression in HGPS-like patients: a transcriptional study.Detection of EpCAM-positive microparticles in pleural fluid: A new approach to mini-invasively identify patients with malignant pleural effusions.A Heterozygous ZMPSTE24 Mutation Associated with Severe Metabolic Syndrome, Ectopic Fat Accumulation, and Dilated CardiomyopathyCytology-based treatment decision in primary lung cancer: is it accurate enough?Nuclear matrix, nuclear envelope and premature aging syndromes in a translational research perspective.Low lamin A expression in lung adenocarcinoma cells from pleural effusions is a pejorative factor associated with high number of metastatic sites and poor Performance status.Correction: HIV Protease Inhibitors Do Not Cause the Accumulation of Prelamin A in PBMCs from Patients Receiving First Line Therapy: The ANRS EP45 “Aging” Study.microRNA deregulation in Hutchinson-Gilford Progeria.Large-scale expression study of human mesial temporal lobe epilepsy: evidence for dysregulation of the neurotransmission and complement systems in the entorhinal cortex.Detection of EGFR, KRAS and BRAF mutations in metastatic cells from cerebrospinal fluid.Morphology quiz: Mediastinal adenopathy cytology from endobronchial ultrasound transbronchial aspiration (EBUS-TBNA).Chronic use of proton pump inhibitors, adverse events and potential biological mechanisms: A translational analysis.MicroRNAs in hereditary and sporadic premature aging syndromes and other laminopathies.An overview of treatment strategies for Hutchinson-Gilford Progeria syndrome.A New Lamin A Mutation Associated with Acrogeria SyndromeHigh prevalence of laminopathies among patients with metabolic syndromeNovel LMNA Mutation in Atypical Werner Syndrome Presenting With Ischemic DiseaseDeletions of chromosomes 1p and 19q are detectable on frozen smears of gliomas by FISH: usefulness for stereotactic biopsiesCombined search for anti-beta2-glycoprotein I and anticardiolipin antibodies in antiphospholipid syndrome: contribution to diagnosis[Role of DNA microarrays in the diagnosis of pleural exudates: a feasibility study]Novel familial cases of ICCA (infantile convulsions with paroxysmal choreoathetosis) syndromeIdentification of CD146 as a novel molecular actor involved in systemic sclerosis
P50
Q24684993-C5EAEFBC-DFA2-46D2-83DD-160C150F845DQ28271719-81B64063-AB2C-4EA2-A116-0A8C958EDD43Q28729025-65474A4F-CAA1-4F0D-9040-B90400D1EE4CQ33700488-6F8CB5BF-5C96-4265-B71A-C671900EFFCBQ33741872-F2EA4973-7B9A-4833-AFE3-CF6431D3D882Q33948504-D07A3E03-A52F-4948-8A6E-87C1B659263FQ34341154-73FA3C81-0B31-40D8-8448-93D8F42C3ECBQ34497301-FDBCD6DC-5DF9-43EF-9DAD-BA0147632FA3Q34534986-F1793F38-687C-4379-BF8E-D2C5BCD77F62Q34892022-E89CD631-25EC-422D-88E2-5212FCABF3AAQ35150458-19068158-7CFF-4145-9BB4-F7484C086A8DQ35906678-34278C54-1AC3-46EE-864D-2F3F06341BA1Q36695378-1DECF802-A4EB-42A8-939C-65857C57CB6FQ36772138-8C5E9892-DF27-4AD4-B353-26B12B4FE374Q37062020-10FBCC0E-9326-468F-A8C8-0F5691BC708AQ37942723-3C61ECFA-C6E6-4664-BB97-D66C9E1D529DQ38198924-6AFDF3B7-7AD9-402F-865B-164EA6F9CBB3Q41383757-6F2B6D10-3D0B-4264-AF9C-0B364C524E21Q45818294-6BB4F52C-51EE-4DC5-8005-036474BE252DQ45920819-791305FD-0DDB-4C66-B861-F440DA214575Q46884649-66AD0557-5157-4490-AC3B-DF7ADB3127A5Q47557503-9AA0E042-B2C5-44EA-AB25-C44E32E46CECQ48095264-24AFC8D2-0EFB-43BC-B66C-90CF601AA877Q50059490-54765256-4911-4680-8A12-178721EF468EQ52562166-54B7EDA2-D321-4A66-86F5-CECA8B326765Q55004770-0DB193E4-E44C-4549-9D1E-1E788F3E96D0Q57554939-E58FBAE6-4F76-4C61-8A22-BA539261EF58Q57611759-E916222C-FCB6-491D-B5AB-E3A995130231Q58376314-866AEB23-8779-4055-8037-367D3E4DFF9CQ80244932-F019D975-B211-4B7E-9409-6DEAAD8967CBQ80800889-8BD9764F-7A37-4DC1-A938-7A2529EEDABAQ81415520-16820837-452D-4F5A-848C-F9765439A0E8Q84754535-6296B903-1036-4EA6-B37D-5CD19571F42BQ88295641-61F8DFBE-4507-40E8-BCD8-0A0A4C4DD3D1
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Patrice Roll
@ast
Patrice Roll
@en
Patrice Roll
@es
Patrice Roll
@nl
type
label
Patrice Roll
@ast
Patrice Roll
@en
Patrice Roll
@es
Patrice Roll
@nl
prefLabel
Patrice Roll
@ast
Patrice Roll
@en
Patrice Roll
@es
Patrice Roll
@nl
P106
P31
P496
0000-0002-0045-5641